Results for this period
Full year1 April 2025 to 31 March 2026ConsolidatedJapanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ million).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
Sales increased in both the Industrial Rubber Business and the Medical and Hygiene Rubber Business. In the Industrial Rubber Business, orders increased for precision rubber products used in operating components, such as O-rings and switches, as well as rubber for table-tennis rackets. In the Medical and Hygiene Rubber Business, sales increased for rubber stoppers for blood collection and drug solution mixing. Profit in the Medical and Hygiene Rubber Business declined, however, due to changes in the product mix.
No applicable matters
| Item | Details |
|---|---|
| Fiscal Period Classification | Full year |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 April 2025 to 31 March 2026 |
| Net Sales | ¥7,852 million (YoY +2.8%) |
| Operating profit | ¥197 million |
| Ordinary income | ¥189 million (YoY +507.7%) |
| Profit attributable to owners of the parent | ¥158 million |
| Net income per share | ¥35.07 |
| Operating Margin | 2.5％ |
| Equity ratio | End of the current fiscal period 51.6％ / End of previous period 52.5％ |
| Total assets | ¥9,731 million |
| Net assets | ¥5,024 million |
| Cash flows from operating activities | ¥835 million |
| Cash flows from investing activities | ¥-674 million |
| Cash flows from financing activities | ¥215 million |
| Cash and cash equivalents at end of period | ¥1,591 million |
| Full-year earnings forecast | Net Sales ¥8,172 million (YoY +4.1%) / Operating profit ¥148 million (YoY -25.2%) / Ordinary income ¥122 million (YoY -35.6%) / Net income ¥85 million (YoY -46.5%) |
| Annual Dividend Forecast | ¥20 per share → ¥24 per share（+20.0%） |
| Payout ratio | 57.0％ |
| Segment revenue | Industrial Rubber Business ¥5,947.01 million (YoY +1.2%), Medical and Hygiene Rubber Business ¥1,905.08 million (YoY +7.9%) |
| Segment profit | Industrial Rubber Business ¥305.15 million (YoY +165.8%), Medical and Hygiene Rubber Business ¥131.93 million (YoY -24.4%) |
| Regional sales | Japan Current fiscal year ¥5,968.46 million / Previous period ¥5,825.19 million / China Current fiscal year ¥1,240.92 million / Previous period ¥1,198.50 million / Asia Current fiscal year ¥472.84 million / Previous period ¥494.12 million / North America Current fiscal year ¥135.44 million / Previous period ¥92.51 million / Europe Current fiscal year ¥34.43 million / Previous period ¥29.27 million / Other Current fiscal year ¥0 million / Previous period ¥0 million |
| Depreciation and amortization | ¥494,043 thousand |
| Impairment loss | No impairment loss was recorded for the fiscal year |
| Breakdown of extraordinary income (loss) | Extraordinary income Insurance proceeds received ¥18,319 thousand, Reversal of provision for contingent losses ¥10,947 thousand / Total extraordinary income ¥29,267 thousand / Extraordinary loss Loss on Disposal of Fixed Assets ¥7,078 thousand / Total extraordinary loss ¥7,078 thousand |
| Disclosure regarding the going concern assumption | No applicable matters |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | New 0 / Excluded 0 / Company name None |
| Material subsequent events | No applicable matters. |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | Whether applicable Yes / Subject person Institutional investors and securities analysts |
| Issued Shares at Period-End | 4,618,520 Shares |
| Treasury Shares at Period-End | 130,845 Shares |
| Factors Behind Changes in Business Performance | Sales increased in both the Industrial Rubber Business and the Medical and Hygiene Rubber Business. In the Industrial Rubber Business, orders increased for precision rubber products used in operating components, such as O-rings and switches, as well as rubber for table-tennis rackets. In the Medical and Hygiene Rubber Business, sales increased for rubber stoppers for blood collection and drug solution mixing. Profit in the Medical and Hygiene Rubber Business declined, however, due to changes in the product mix. |
Items this document does not state (3)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.For the fiscal year ended March 2026, revenue increased because sales grew in both the Industrial Rubber Business and the Medical and Hygiene Rubber Business. For the fiscal year ending March 2027, the company expects orders to increase for precision rubber products for automotive-related applications, rubber for table-tennis rackets and medical products, while proceeding with investments in new product development and the establishment and rationalization of a new production system.